|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities | |||||
| Net income (loss) | |||||
| Adjustments for non-cash items: | |||||
| Depreciation and depletion (includes impairments) | |||||
| (Gain) loss on asset sales | |||||
| Deferred income taxes and other | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventories, materials, supplies and prepaid expenses | |||||
| Income taxes payable | |||||
| Accounts payable and accrued liabilities | |||||
| All other items - net | |||||
| Cash flows from (used in) operating activities | |||||
| Investing activities | |||||
| Additions to property, plant and equipment | |||||
| Proceeds from asset sales | |||||
| Additional investments | |||||
| Loans to equity companies - net | |||||
| Cash flows from (used in) investing activities | |||||
| Financing activities | |||||
| Short-term debt - net | |||||
| Long-term debt - reduction (note 14) | |||||
| Finance lease obligations - reduction | |||||
| Dividends paid | |||||
| Common shares purchased | |||||
| Cash flows from (used in) financing activities | |||||
| Increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of year | |||||
| Cash and cash equivalents at end of year | |||||
Loading...
